![Chiaojung Jillian Tsai: CURB randomized phase 2 RCT of SBRT for oligoprogressive metastatic NSCLC and breast cancer](https://oncodaily.com/pub/uploads/2023/12/download-1-1-e1703096790631-1280x823.png)
Photo taken from Chiaojung Jillian Tsai/LinkedIn
Dec 21, 2023, 09:57
Chiaojung Jillian Tsai: CURB randomized phase 2 RCT of SBRT for oligoprogressive metastatic NSCLC and breast cancer
Chiaojung Jillian Tsai, Lead of Palliative Radiotherapy and Oligometastasis Program (PROP) at Princess Margaret Cancer Centre, posted on LinkedIn:
“Just out The Lancet:
-
ASCO Annual Meeting
May 30 - June 4, 2024
-
Yvonne Award 2024
May 31, 2024
-
OncoThon 2024, Online
Feb. 15, 2024
-
Global Summit on War & Cancer 2023, Online
Dec. 14-16, 2023